Pharmaceutical Preparations
Stocks Ranked by
Market Capitalization

Filters

#	Name	Market cap	Price	Price change %
1	1 Eli Lilly LLY $778B	$778B	$818.86	-1.63%
2	2 Johnson & Johnson JNJ $367B	$367B	$152.64	-1.55%
3	3 AbbVie ABBV $302B	$302B	$171.09	-1.91%
4	4 Merck MRK $249B	$249B	$98.58	-2.13%
5	5 Abbott ABT $202B	$202B	$116.44	-0.31%
6	6 Pfizer PFE $148B	$148B	$26.19	-0.19%
7	7 Vertex Pharmaceuticals VRTX $126B	$126B	$490	-2.34%
8	8 Bristol-Myers Squibb BMY $120B	$120B	$59.02	-1.34%
9	9 Regeneron Pharmaceuticals REGN $90.2B	$90.2B	$821	-0.57%
10	10 Zoetis ZTS $78.5B	$78.5B	$173.96	-1.24%
11	11 Alnylam Pharmaceuticals ALNY $34.7B	$34.7B	$268.95	-3.88%
12	12 BeiGene BGNE $20.6B	$20.6B	$193.64	-5.56%
13	13 Teva Pharmaceuticals TEVA $19.4B	$19.4B	$17.11	-1.5%
14	14 United Therapeutics UTHR $17.9B	$17.9B	$400.87	+0.11%
15	15 Tenet Healthcare THC $16B	$16B	$164.21	-1.58%
16	16 Viatris VTRS $15.4B	$15.4B	$12.93	-1.22%
17	17 Summit Therapeutics SMMT $15.3B	$15.3B	$20.76	-4.64%
18	18 BioMarin Pharmaceuticals BMRN $12.6B	$12.6B	$66.13	-0.36%
19	19 Insmed INSM $12.5B	$12.5B	$70.14	-2.34%
20	20 Royalty Pharma RPRX $11.6B	$11.6B	$26	-1.37%
21	21 Sarepta Therapeutics SRPT $10.9B	$10.9B	$114.32	-2.99%
22	22 Catalent CTLT $10.8B	$10.8B	$59.25	-0.35%
23	23 Intra-Cellular Therapies ITCI $9.38B	$9.38B	$88.49	-3.36%
24	24 Roivant Sciences ROIV $8.61B	$8.61B	$11.64	-1.44%
25	25 Jazz Pharmaceuticals JAZZ $7.72B	$7.72B	$127.74	+0.49%